|
Tiratricol |
|---|---|
| Trade Name | Triacana |
| Orphan Indication | For use in combination with levo-thyroxine to suppress thyroid stimulating hormone in patients with well-differentiated thyroid cancer who are intolerant to adequate doses of levo-thyroxine alone |
| USA Market Approval | USA |
| USA Designation Date | 1991-08-13 00:00:00 |
| Sponsor | Laphal Laboratoires;48 Bis, Rue des Belles-Feuilles, 75116 Paris; |
